|
DoP
invites eligible medical devices firms to apply for newly
formed Category B of PLI scheme
The Department of
Pharmaceuticals (DoP) has called for applications from
eligible medical devices firms for the newly created
Category B of the production linked incentive (PLI) scheme
for promoting domestic manufacturing of medical devices.
The Department, on August 18, revised the guidelines of
the Scheme creating a second category of medical devices
by dividing the eligible products in the single category
of medical devices it had in the initial guidelines issued
in 2020. Eligible applicants for Category B may apply
through online mode from September 1, 2022 and the last
date of receipt of complete application is October 31,
2022.
With the revised guideline, the list of medical devices in
the Annexure 1 of the guideline has been referred as
Category A, while a newly bifurcated Annexure 1A has been
referred to as Category B. Changes were also been made in
other clauses and Annexures based on this revision.
The application window for the PLI scheme according to the
previous guideline ended on November 30, 2022, but the
revised guideline has provisions to keep the application
window open based on notice issued by the Department from
time to time.
The previous guideline fixed that a maximum of 28
applicants shall be selected under the scheme, with a
maximum of 10 applicants under each target segment.
According to the revised guidelines, the number of
applicants shall be selected under the scheme based on
availability of outlay approved under the scheme.
The department has earlier said that with an objective to
boost domestic manufacturing, attract large investment in
the medical device sector, it had launched a production
linked incentive (PLI) scheme for promotion of domestic
manufacturing of medical devices to ensure a level playing
field for the domestic manufacturers of medical devices
with a total financial outlay of Rs. 3,420 crore for the
period 2020-21 to 2027-28.
In the first round, 28 applications were received from 23
applicants under the Scheme. Out of which, 13 applications
with committed investment of Rs. 798.93 crore by the
companies were approved with expected employment
generation of around 3,812 persons. Since few slots
remained unfilled for certain products, applications were
invited again with the last date of submission as August
31, 2021 and a total of 14 applications were received. It
has approved eight plants in an EC meeting held on
November 25, 2021. The DoP has recently released a list of
21 applications approved under the scheme till then.
http://www.pharmabiz.com/NewsDetails.aspx?aid=152871&sid=1
; August 27
|
